share_log

公告精选 | 融创中国拟折让15%配售4.52亿股股份;中信证券2021年净利同比增长54.2%

Selected Announcements | Sunac China plans to place 452 million shares at a 15% discount; CITIC Securities's net profit increased 54.2% year-on-year in 2021

富途資訊 ·  Jan 13, 2022 08:20

Selection of blockbuster announcements

1、$Sunac China (01918.HK) $It is proposed to place 452 million shares at a 15% discount

Sunac China announced on the Hong Kong Stock Exchange that he intends to place 452 million placing shares at HK $10 each, with a total proceeds of HK $4.52 billion. The placing price is HK $10 per share, a discount of about 15.3% from the closing price of HK $11.80 on January 12, 2022.

2、$CITIC (06030.HK) $KuaiBao: net profit in 2021 increased by 54.2% compared with the same period last year

CITIC announced that in 2021, the company realized operating income of 76.57 billion yuan, an increase of 40.80 percent over the same period last year, and realized net profit of 22.979 billion yuan belonging to shareholders of the parent company, an increase of 54.20 percent over the same period last year. Net profit belonging to shareholders of the parent company after deducting non-recurring profits and losses was 23.186 billion yuan, an increase of 55.61 percent over the same period last year; and basic earnings per share was 1.77 yuan.

3、$Petrochina (00857.HK) $Net profit in 2021 increased by 374% Murray 395% compared with the same period last year

Petrochina announced that it is expected that the net profit attributed to the company's shareholders in 2021 will increase by 71 billion yuan to 75 billion yuan, an increase of 374% to 395% compared with the same period last year, and an increase of 44.3 billion yuan to 48.3 billion yuan compared with the same period in 2019, an increase of 97% to 106%, with an average two-year growth of 40% to 43%, the best level for the same period in nearly seven years.

4、$Tigermed (03347.HK) $Net profit in 2021 is 50% more than that of the same period last year.

Tigermed announced that the net profit in 2021 is expected to be 2.62 billion yuan to 3.03 billion yuan, an increase of 50% over the same period last year. The company's direct or indirect investment in biomedicine, medical devices and companies related to the company's main business recognized fair value changes of 1.2 billion yuan to 1.6 billion yuan in accordance with the new financial instruments standards.

5、$The People's Insurance (01339.HK) $The original premium income totaled 581.047 billion yuan in 2021, an increase of 3.67% over the same period last year.

The People's Insurance announced that from January 1, 2021 to December 31, 2021, the original insurance premium income obtained by the company's subsidiaries China people's property Insurance Co., Ltd., China people's Life Insurance Co., Ltd. And China people's Health Insurance Co., Ltd. is 448.384 billion yuan, 96.847 billion yuan and 35.816 billion yuan respectively, totaling 581.047 billion yuan A year-on-year increase of 3.67%.

Performance forecast

CITIC (06030) released results KuaiBao: net profit in 2021 increased by 54.2% year on year

Petrochina (00857): net profit in 2021 increases by 374% to 395%

Crystal Gate Semiconductor (02878) Yingxi: annual net profit increases by more than 100%

Tigermed (03347) expects annual net profit to increase by 50% to 73%.

Jiahong Logistics (02130) Yingxi: net profit attributable to equity shareholders for the year increased significantly by not less than 45%

Weili Group (00806) earnings Police: it is estimated that the share of consolidated net profit attributable to company owners will decrease by 67%.

Operation data

The People's Insurance (01339) the original premium income totaled 581.047 billion yuan in 2021, an increase of 3.67% over the same period last year.

PICC Property and Casualty (02328) the original premium income totaled 448.384 billion yuan last year, an increase of 3.8% over the same period last year.

Datang New Energy (01798) accumulated 26.1784 million megawatt-hours of electricity in 2021, an increase of 23.62% over the same period last year.

China Resources Land (01109) cumulative contract sales of about 315.76 billion yuan in 2021 increased by 10.8% over the same period last year.

Merger and acquisition and sale

Jiahong Education (01935): the Institute of Economics and Trade plans to buy Binzhou property with 119 million yuan.

Central Asia Valley Group (00063) intends to sell all its shares in Sky Heritage for HK $10, 000

Offer for privatization

HNA Technology Investment (02086) received a discount of 25.66% from Mars Development and Megacore Development and offered to resume trading tomorrow.

Investment and operation

CSPC Pharmaceutical (01093): lemvatinib mesylate capsule was approved for drug registration.

Shanghai Fosun Pharmaceutical (02196): Jiangsu Wanbang passed the American FDA on-the-spot inspection

HUTCHMED (China) Limited (00013): HMPL-523 has been included in breakthrough therapeutic drugs for the treatment of primary immune thrombocytopenia in China.

Haohai Biotechnology (06826) received a total of 28.2128 million yuan in government subsidies.

Hong Kong Ferry (Group) (00050)'s stock price fluctuates abnormally, considering diversifying its business to medical beauty and health care.

Shanghai Fudan (01385) recently received a total of about 15.5791 million yuan in government subsidies.

Repurchase cancellation

Tianlun Gas (01600) spent HK $18.6288 million to buy back 2.2 million shares on January 12th.

Yi Da (01733) spent HK $11.9411 million to buy back 10.512 million shares on January 12.

Foreign Exchange Technology (01860) spent HK $2.1398 million to buy back 309000 shares on January 12.

Color Star Group (00635) spent HK $1.6 million to buy back 2 million shares on January 12.

Haohai Biotechnology (06826) bought back 74600 shares at a cost of HK $4.0823 million on January 12.

Yongda Motor (03669) spent HK $4.664 million to buy back 500000 shares on January 12.

Riqing Food (01475) spent HK $2.5452 million to buy back 400000 shares on January 12.

Net Dragon (00777) spent HK $3.6573 million to buy back 200000 shares on January 12.

Harmonious Automobile (03836) bought back 439000 shares at a cost of HK $2.08 million on January 12th

Haohai Biotechnology (06826) bought back 74600 shares at a cost of HK $4.0823 million on January 12.

Edit / somer

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment